Evaxion AS (EVAX)
3.15
+0.17
(+5.70%)
USD |
NASDAQ |
Sep 02, 11:00
Evaxion Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0008M |
| September 30, 2023 | -0.0649M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -0.1586M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.1792M |
| September 30, 2021 | -0.3283M |
| June 30, 2021 | -0.4942M |
| March 31, 2021 | -0.3262M |
| December 31, 2020 | -0.2827M |
| September 30, 2020 | 0.0135M |
| June 30, 2020 | -0.0455M |
| March 31, 2020 | -0.081M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Autolus Therapeutics Plc | 68.03M |
| Cellectis SA | 18.75M |
| Akari Therapeutics Plc | 0.00 |
| DBV Technologies SA | -0.5998M |
| argenx SE | -- |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow Yield | -116.6% |